Health
How rare are blood clots after the AstraZeneca vaccine? What should you look out for? And how are they treated? – The Conversation AU
The clotting condition has affected one in 88,000 Australians and is less deadly than previously thought.
With COVID-19 community transmission on the rise once again, those aged over 50 are weighing up the benefits of being vaccinated against the virus with the very rare risk of blood clotting induced by the AstraZeneca vaccine.
Since the first reports of blood clotting after the AstraZeneca vaccine emerged in March 2021, our understanding of the clotting disorder, called vaccine-induced thrombotic thrombocytopaenia (VITT) or thrombosis with thrombocytopenia syndrome (TTS), has grown.
We now know…
-
Noosa News24 hours agoGaming policy on council’s agenda
-
Noosa News21 hours agoJetstar flights resume across Australia after Airbus A320 software issue identified
-
General14 hours agoHomes under threat as bushfire bears down on properties in Geraldton suburbs
-
Business22 hours ago5 best Australian dividend stocks to buy in December